Skip to Main Content

(2399) A single arm, openlabel, multicenter study evaluating the longterm safety, tolerability and efficacy of 0.5 mg fingolimod (FTY720) administered orally once daily in patients with multiple sclerosis

Principal Investigator

Silvia Delgado

Clinical Trial ID

Institutional Protocol # 20111162

Clinical Trial Summary


Phase III

Funding Agency/Sponsor



Multiple Sclerosis

Contact Information

Study Contact Neurology Research
Phone Number 1-877-977-7724